1. Phase II clinical study of erlotinib for treatment of myelodysplastic syndromes. Issue 8 (16th May 2014) Authors: Komrokji, Rami S.; Padron, Eric; Yu, Daohai; Fulp, William J.; Rodriguez, Yuraima; Tinsley, Sara; List, Alan F.; Lancet, Jeffrey E. Journal: American journal of hematology Issue: Volume 89:Issue 8(2014:Aug.) Page Start: 809 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗